+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "CD28"

Anti-CD28 Antibody - Pipeline Insight, 2024 - Product Thumbnail Image

Anti-CD28 Antibody - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 60 Pages
  • Global
From
From
CAR-T Therapy - Pipeline Insight, 2024 - Product Thumbnail Image

CAR-T Therapy - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 550 Pages
  • Global
From
CAR T-cell Therapy - Pipeline Insight, 2024 - Product Thumbnail Image

CAR T-cell Therapy - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 60 Pages
  • Global
From
Anti-CD279 (PD-1) Antibody - Pipeline Insight, 2024 - Product Thumbnail Image

Anti-CD279 (PD-1) Antibody - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 90 Pages
  • Global
From
From
Checkpoint Inhibitors: Global Markets - Product Thumbnail Image

Checkpoint Inhibitors: Global Markets

  • Report
  • October 2018
  • 141 Pages
  • Global
From
Checkpoint Inhibitors - Competitive landscape, 2023 - Product Thumbnail Image

Checkpoint Inhibitors - Competitive landscape, 2023

  • Report
  • April 2023
  • 350 Pages
  • Global
From
CAR T - Cell Therapy - Competitive landscape, 2023 - Product Thumbnail Image

CAR T - Cell Therapy - Competitive landscape, 2023

  • Report
  • April 2023
  • 500 Pages
  • Global
From
CTLA-4 inhibitors- Competitive landscape, 2023 - Product Thumbnail Image

CTLA-4 inhibitors- Competitive landscape, 2023

  • Report
  • May 2023
  • 220 Pages
  • Global
From
From
From
T Cell Specific Surface Glycoprotein CD28 - Pipeline Review, H2 2019 - Product Thumbnail Image

T Cell Specific Surface Glycoprotein CD28 - Pipeline Review, H2 2019

  • Drug Pipelines
  • December 2019
  • 73 Pages
  • Global
From
Protein Kinase C Theta Type - Pipeline Review, H2 2020 - Product Thumbnail Image

Protein Kinase C Theta Type - Pipeline Review, H2 2020

  • Drug Pipelines
  • July 2020
  • 33 Pages
  • Global
From
Cytotoxic T Lymphocyte Protein 4 - Pipeline Review, H2 2019 - Product Thumbnail Image

Cytotoxic T Lymphocyte Protein 4 - Pipeline Review, H2 2019

  • Drug Pipelines
  • November 2019
  • 237 Pages
  • Global
From
  • 17 Results (Page 1 of 1)
Loading Indicator

CD28 is a type of oncology drug that works by blocking the activity of a protein called CD28, which is found on the surface of certain types of cancer cells. This protein is involved in the growth and spread of cancer cells, and blocking its activity can help to slow down the progression of the disease. CD28 drugs are used in combination with other treatments, such as chemotherapy and radiation therapy, to help improve the effectiveness of these treatments. They are also used to reduce the side effects of these treatments, such as nausea and fatigue. CD28 drugs are used to treat a variety of different types of cancer, including breast, lung, and colorectal cancer. They are also used to treat some types of leukemia and lymphoma. CD28 drugs are generally well tolerated and have few side effects. Companies in the CD28 market include Novartis, Merck, Pfizer, and AstraZeneca. These companies are involved in the research, development, and marketing of CD28 drugs. They are also involved in the production and distribution of these drugs to healthcare providers and patients. Show Less Read more